We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has retracted a warning letter previously issued to medical device manufacturer Ophtec after finding that citations in the letter were “factually inaccurate,” Ophtec President Rick McCarley said.